California State Teachers Retirement System (CalSTRS)
AVTX icon

California State Teachers Retirement System (CalSTRS)’s Avalo Therapeutics AVTX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9
Closed -$19K – 3144
2022
Q1 		$19K Sell
9
-3
-25% -$7.54K ﹤0.01% 3172
2021
Q4 		$60K Buy
12
+2
+20% +$12K ﹤0.01% 3127
2021
Q3 		$62K Sell
10
-15
-60% -$122K ﹤0.01% 3091
2021
Q2 		$240K Buy
25
+2
+9% +$16.8K ﹤0.01% 2966
2021
Q1 		$196K Buy
23
+4
+21% +$37.8K ﹤0.01% 2897
2020
Q4 		$145K Buy
19
+2
+12% +$13.9K ﹤0.01% 2949
2020
Q3 		$110K Buy
17
+5
+42% +$37.6K ﹤0.01% 2950
2020
Q2 		$87K Hold
12
– – ﹤0.01% 2968
2020
Q1 		$83K Buy
12
+1
+9% +$10.6K ﹤0.01% 2844
2019
Q4 		$178K Hold
11
– – ﹤0.01% 2822
2019
Q3 		$109K Hold
11
– – ﹤0.01% 2925
2019
Q2 		$180K Buy
+11
New +$167K ﹤0.01% 2884

Other funds holding AVTX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s AVTX Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Avalo Therapeutics (AVTX) in Q2 2022, closing a stake of 9 shares — an estimated $19K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in AVTX in Q2 2019 and held it in 12 quarters. The position peaked at $240K in Q2 2021. 43 funds tracked by Wall St. Rank hold AVTX as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Avalo Therapeutics position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 9 Avalo Therapeutics shares in Q2 2022, an estimated $19K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Avalo Therapeutics in Q2 2019 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Avalo Therapeutics position peaked at $240K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.